Celeris Therapeutics
Graz, Austria
Celeris Therapeutics is the pioneer in the AI-driven discovery of degraders against currently incurable diseases.Our innovative and patent-pending methods exploit the ubiquitin-proteasome system by predicting biomolecular interactions and ternary complexes and generating heterobifunctional and glue degrader molecules. Celeris One is a platform for Targeted Protein Degradation to collaborate with pharmaceutical and biotech companies. CelerisTx' drug pipeline, which is fully owned, addresses unmet medical needs.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- celeristx.com
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Celeris Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now